ES8505409A1 - Procedimiento para purificar interferon de humano - Google Patents

Procedimiento para purificar interferon de humano

Info

Publication number
ES8505409A1
ES8505409A1 ES535509A ES535509A ES8505409A1 ES 8505409 A1 ES8505409 A1 ES 8505409A1 ES 535509 A ES535509 A ES 535509A ES 535509 A ES535509 A ES 535509A ES 8505409 A1 ES8505409 A1 ES 8505409A1
Authority
ES
Spain
Prior art keywords
human interferon
procedure
purify human
cells
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535509A
Other languages
English (en)
Other versions
ES535509A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of ES535509A0 publication Critical patent/ES535509A0/es
Publication of ES8505409A1 publication Critical patent/ES8505409A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

METODO DE PURIFICACION DE INTERFERON DE HUMANO.CONSISTE EN PURIFICAR INTERFERON DE HUMANO DEL TIPO BAB MEDIANTE CROMATOGRAFIA A TRAVES DE UNA COLUMNA DE AFINIDAD DE ANTICUERPO DE IGC, FIJADO COVALENTEMENTE A UN SOPORTE, TAL COMO SEPHAROSE ACTIVADO; SEGUIDO DE LA PURIFICACION A TRAVES DE UN INTERCAMBIADOR DE CATIONES ACIDO.
ES535509A 1983-02-22 1984-08-30 Procedimiento para purificar interferon de humano Expired ES8505409A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306060 DE3306060A1 (de) 1983-02-22 1983-02-22 Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ES535509A0 ES535509A0 (es) 1985-05-16
ES8505409A1 true ES8505409A1 (es) 1985-05-16

Family

ID=6191474

Family Applications (2)

Application Number Title Priority Date Filing Date
ES529912A Granted ES529912A0 (es) 1983-02-22 1984-02-21 Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano
ES535509A Expired ES8505409A1 (es) 1983-02-22 1984-08-30 Procedimiento para purificar interferon de humano

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES529912A Granted ES529912A0 (es) 1983-02-22 1984-02-21 Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano

Country Status (7)

Country Link
EP (1) EP0119476A3 (es)
JP (1) JPS59224687A (es)
DE (1) DE3306060A1 (es)
DK (1) DK85084A (es)
ES (2) ES529912A0 (es)
FI (1) FI840675A7 (es)
IL (1) IL71017A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
GB8615353D0 (en) * 1986-06-24 1986-07-30 Antibioticos Sa Interferon
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
SE468251B (sv) 1989-06-20 1992-11-30 Bionative Ab Reningsprocess foer interferon
DK0538300T3 (da) * 1990-07-10 1994-10-10 Boehringer Ingelheim Int O-Glycosyleret IFN-alfa
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
JP2010512315A (ja) 2006-12-06 2010-04-22 メディミューン，エルエルシー インターフェロンα誘導性薬力学的マーカー
CA2685147A1 (en) 2007-05-03 2008-11-13 Medimmune, Llc Auto-antibody markers of autoimmune disease
BRPI0819195A2 (pt) 2007-11-05 2017-05-23 Medimmune Llc métodos para tratar escleroderma em um paciente em necessidade de tal tratamento e para aliviar um ou mais dos sintomas associados com escleroderma em um paciente em necessidade de tal tratamento.
MX2010008698A (es) 2008-02-08 2010-12-20 Medimmune Llc Marcadores de enfermedad y usos de los mismos.
AU2010289383B2 (en) 2009-09-03 2015-04-16 Medimmune, Llc Type 1 interferon diagnostic
SG11202108679PA (en) 2019-02-15 2021-09-29 Astrazeneca Ab Type i interferon-mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
GB2083836B (en) * 1980-04-11 1984-03-28 Burke Derek Clissold Monoclonal antibody
AU561649B2 (en) * 1981-02-27 1987-05-14 F. Hoffmann-La Roche Ag Antibodies to proteins
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
GB8303165D0 (en) * 1983-02-04 1983-03-09 Secher D S Monoclonal antibody

Also Published As

Publication number Publication date
ES8503371A1 (es) 1985-02-16
DE3306060A1 (de) 1984-08-23
ES535509A0 (es) 1985-05-16
EP0119476A3 (de) 1987-04-08
FI840675L (fi) 1984-08-23
DK85084A (da) 1984-08-23
IL71017A (en) 1987-12-31
FI840675A7 (fi) 1984-08-23
JPS59224687A (ja) 1984-12-17
DK85084D0 (da) 1984-02-21
IL71017A0 (en) 1984-05-31
ES529912A0 (es) 1985-02-16
FI840675A0 (fi) 1984-02-20
EP0119476A2 (de) 1984-09-26

Similar Documents

Publication Publication Date Title
DE3580654D1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
JPS55145617A (en) Hybrid cell line* antibody and method for manufacturing complementtfixing monoclonal antibody against human t cell
JPS5695123A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
EP0176355A3 (en) Antigen-independent immunoassay system
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
NO159622C (no) Monoklonalt antistoff.
ZA802524B (en) Hybrid cell line for producing monoclonal antibody to human helper t cells,antibody,and methods
ATE14233T1 (de) Monoklonaler antikoerper gegen menschliche tzellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
PH16819A (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells,antibody and methods
NO159887C (no) Monoklonalt antistoff.
ES8200559A1 (es) Un anticuerpo monoclonal
DE3581400D1 (de) Maus/mensch-hybridoma mit erzeugung von antiviralen menschlichen antikoerpern, deren herstellung und antivirale menschliche monoklonale antikoerper.
GB2083836A (en) Monoclonal antibody
ES8503371A1 (es) Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano
IL70993A0 (en) Hybrid cell lines,their production,monoclonal antibodies to legionella pneumophila produced thereby and their use
JPS6447391A (en) Monoclonal antibody and use thereof
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
EP0225583A3 (en) Monoclonal anti-human granulocyte colony stimulating factor antibody
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
EP0287012A3 (en) Anti-r-binder monoclonal antibody, process for preparing the same and application of the same
NO874799L (no) Fremgangsmaate for fremstilling av monoklonale antistofferved dyrking av hybridom-cellelinjen lym-2.
HRP940809B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody and methods

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990301